| Literature DB >> 16722539 |
Sylvia J Hysong1, Richard G Best, Jacqueline A Pugh.
Abstract
BACKGROUND: As a strategy for improving clinical practice guideline (CPG) adherence, audit and feedback (A&F) has been found to be variably effective, yet A&F research has not investigated the impact of feedback characteristics on its effectiveness. This paper explores how high performing facilities (HPF) and low performing facilities (LPF) differ in the way they use clinical audit data for feedback purposes.Entities:
Year: 2006 PMID: 16722539 PMCID: PMC1479835 DOI: 10.1186/1748-5908-1-9
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Number of participants by facility and hierarchical level
| Primary Care Personnel | Middle/Support Management | Facility Leadership | ||||
| High Performers | 1 | 14 | 2 | 3 | 19 | 8 |
| 2 | 6 | 10 | 7 | 23 | 14 | |
| 3 | 7 | 4 | 3 | 14 | 9 | |
| Low Performers | 4 | 4 | 8 | 4 | 16 | 8 |
| 5 | 3 | 4 | 4 | 11 | 7 | |
| 6 | 7 | 10 | 2 | 19 | 8 | |
| Total | 41 | 38 | 23 | 102 | 54 | |
Note: Facilities are listed in decreasing order of performance. No significant differences in the distributions of participants were found by facility or hierarchical level (χ210 = 17.4, n.s.).
Patterns of feedback properties by facility
| 1 | 2 | 3 | 4 | 5 | 6 | |
| Timely | E | E | E | E | C | C |
| Individualized | E | E | C | N | N | N |
| Non-Punitive | E | E | I | I | N | I |
| Customizable | I | I | I | N | N | I |
Note: E = Evidence was observed that the property in question was present at that facility; C = conflicting evidence; I = insufficient evidence; and N = negative evidence, i.e., evidence that the opposite property was present (e.g., an N for facility 4 on individualized means that there is evidence that the feedback is not individualized).
Figure 1A Model of Actionable Feedback. *The use of the term optimal to describe the effect on performance is relative – by this we mean optimal, given the variables in the emergent model. There are certainly other factors which could affect performance, although they are not exhibited here.
Interview Guide
| 1. How do you or your staff identify quality of care issues in need of improvement for your | ||
| a. Who would be responsible for initiating and carrying out such efforts? | ||
| b. Who would be responsible for monitoring such efforts? | ||
| 2. What does the term "Clinical Practice Guidelines" mean to you? | a. What role do you see for clinical practice guideline use as a method for improving quality of care? | |
| b. Do you believe clinical practice guidelines are effective for improving quality of care? Please explain. | ||
| 3. How do guidelines help you improve the quality of care you provide your patients? | a. As a source of data feedback? | |
| b. How is data collected and utilized in your facility to improve the quality of patient care (e.g., administrative "scorekeeping" or as feedback for improving the quality of care)? | ||
| c. Was EPRP data or other data on performance distributed? | ||
| d. Did EPRP results affect individual performance evaluations? | ||
| e. Does the facility collect clinical outcome data (mortality, readmission, functional status) related to the guideline? | ||
| 4. Could you tell us the story of a time you and your team successfully implemented a clinical practice guideline (e.g., smoking cessation, depression screening, diabetes mellitus, hypertension, etc.)? | ||
| a. What were the steps? | ||
| b. Who was involved? To what extent are clinicians involved in determining how to implement guidelines? | ||
| c. How was this guideline effort brought to the attention of clinicians and managers in your facility? (e.g., formal meetings, guideline champions, grand rounds, e-mail distributions, web sites, etc)? | ||
| d. To what extent were committees (one steering committee for all guidelines or guideline specific committees) used to implement guidelines? | ||
| e. What made it a success? | ||
| 5. Please describe the training (i.e., professional development) that clinicians have received for implementing guidelines. | a. Would clinicians say they have been provided adequate support for professional development with respect to CPG implementation? | |
| b. Any training in the use of technology (e.g., CPRS, clinical reminders, etc.)? | ||
| c. CME credit? | ||
| 6. What are the most important factors that facilitate guideline implementation? | a. Technology (CPRS, clinical reminders)? | |
| b. Targeted educational or training programs, patient specific reminder systems, workshops, retreats? | ||
| c. Incentives (e.g., monetary, extra time off from work, gift certificates, etc.)? | ||
| d. Mentoring or coaching? | ||
| e. Additional resources (e.g., equipment, staff, etc.)? | ||
| f. Social Factors such as teamwork or networks? | ||
| g. Representation from a diversity of service lines? | ||
| h. Presence of a guideline champion? | ||
| i. Supportive leadership (i.e., VISN and/or facility)? | ||
| j. Pocket cards or "lite" versions of the guidelines? | ||
| 7. What are the most important factors that hinder guideline implementation? | a. Lack of resources or staff? | |
| b. Time (i.e., patient interactions are targeted for 20 minutes)? | ||
| c. Lack of training? | ||
| d. Not enough support? | ||
| e. Financial? | ||
| 8. Were there any changes or redesigns in the clinical practices or equipment that supported the use of CPGs. | a. How were forms/procedures or reports changed to support adherence to guidelines? | |
| b. How were the responsibilities of nurses, aides, other personnel changed to support adherence? | ||
| c. How were resources allocated/reallocated to support adherence? | ||
| 9. Please describe any other conditions that may influence CPG implementation? | a. Size of the facility? | |
| b. Academic affiliation? | ||
| c. Competition with other QI initiatives? | ||
| d. Location (e.g., remote vs. main facility)? |